Stock listing

Jaguar Health, Inc.

Selected listing: 1JA1 · FWB · EUR · DE

Jaguar Health, Inc. (Frankfurt:1JA1), Health Technology. Latest release Oct 6, 2026: Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring…

1JA1:FWBEURDEUpdated October 2, 2026

Ticker: Frankfurt:1JA1
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Frankfurt
Currency: EUR

Latest news from Jaguar Health, Inc.

Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi

October 5, 2026

Jaguar Health Announces a Special Stock Dividend

October 1, 2026

Jaguar Health Announces a Special Stock Dividend

October 1, 2026

Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting

September 28, 2026

Jaggaer Completes Acquisition of Ivoflow, Bringing AI-Powered Direct Materials Spend & Price Intelligence to Manufacturers

September 14, 2026

All Jaguar Health, Inc. news →

Events

Replays

Jaguar Health, Inc. (JAGX) Q2 2026 Earnings Call
Wed, Aug 19, 2026 · 04:30 PM ET
Watch
Jaguar Health, Inc. (JAGX) Q1 2026 Earnings Call
Tue, May 26, 2026 · 08:30 AM ET
Watch
Jaguar Health, Inc. (JAGX) Q4 2025 Earnings Call
Fri, Apr 10, 2026 · 08:30 AM ET
Watch

Research Jaguar Health, Inc.

Jaguar Health, Inc. company profile

View the public company page for Jaguar Health, Inc. on 6ix.

Jaguar Health, Inc. news

Read company news and market updates connected to Jaguar Health, Inc..

Jaguar Health, Inc. investor events

Find investor webinars, events, and replay context for Jaguar Health, Inc..